At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 40 enrolled
Drug / intervention
Dexamethasone intravitreal implant +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
In Brief
A Phase 2 clinical trial evaluating Dexamethasone intravitreal implant and Steroid plus NSAID eye drop combination therapy for Macular Edema and Diabetes Mellitus. Completed, enrolled 40 participants across 1 site.
Detailed Summary
There is a need to find an effective therapy for diabetic patients who develop macular edema after cataract surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMacular Edema, Diabetes Mellitus
CountriesUnited States
CollaboratorsAllergan
Timeline
Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedAug 2012
Enrollment StartNov 2012
Primary CompletionDec 2014
TodayJul 2026
First PostedAug 27, 2012
Enrollment StartNov 1, 2012
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 13.8 years ago
Interventions
Dexamethasone intravitreal implantdrug
Steroid plus NSAID eye drop combination therapydrug